Related Experiment Video
Updated: Aug 7, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Protective effect of insulin against hypoglycemia-associated counterregulatory failure
B Fruehwald-Schultes1, W Kern, E Deininger
1Department of Internal Medicine I, University of Luebeck, Germany. fruehwal@kfg.mu-luebeck.de
Abstract:
Antecedent hypoglycemic episodes reduce the counterregulatory neuroendocrine response to hypoglycemia. The role of insulin in the mechanism responsible for the antecedent hypoglycemia causing subsequent counterregulatory failure has not been elucidated. We performed antecedent hypoglycemic clamps (56 mg/dL) lasting 2 h with differing degrees of hyperinsulinemia, which were followed by 6-h stepwise hypoglycemic clamps (76-66-56-46 mg/dL) on the next day. Experiments were carried out in 30 young, healthy men. Fifteen of these subjects were tested on 2 occasions. On 1 occasion the antecedent hypoglycemia was induced by insulin infusion at a rate of 1.5 mU/min x kg (low insulin-ante-hypo); on the other occasion the insulin infusion rate was 15.0 mU/min x kg (high insulin-ante-hypo). Both sessions were separated by at least 4 weeks, and their order was balanced across subjects. The remaining 15 subjects (control group) received the same stepwise hypoglycemic clamp as the other subjects, but without antecedent hypoglycemia. During the stepwise hypoglycemic clamp, the counterregulatory increases in ACTH, cortisol, and norepinephrine were significantly blunted after the low insulin-ante-hypo (P < 0.01, P < 0.05, and P < 0.05, respectively) but not after the high insulin-ante-hypo (P = 0.12, P = 0.92, and P = 0.19, respectively) compared to that in the control group. The cortisol, norepinephrine, and glucagon responses were greater after the high than after the low insulin-ante-hypo (all P < 0.05). In conclusion, the present study clearly demonstrates that even a single episode of mild hypoglycemia reduces neuroendocrine counterregulation 18-24 h later. Insulin has a moderate protective effect on subsequent counterregulation.
Insights
Previous hypoglycemia impairs the body's response to low blood sugar. Insulin offers some protection against this impaired counterregulation, highlighting its role in glucose homeostasis.
Area of Science:
- Endocrinology
- Metabolic Regulation
- Neuroscience
Background:
- Recurrent hypoglycemia can blunt the body's counterregulatory response.
- The specific role of insulin in this blunting effect remains unclear.
Purpose of the Study:
- To investigate the impact of antecedent hypoglycemia with varying insulin levels on subsequent counterregulatory responses.
- To elucidate insulin's role in mitigating the effects of prior hypoglycemia on glucose regulation.
Main Methods:
- Healthy men underwent antecedent hypoglycemic clamps with low (1.5 mU/min x kg) or high (15.0 mU/min x kg) insulin infusion.
- Subsequent stepwise hypoglycemic clamps were performed the next day.
- Counterregulatory hormone levels (ACTH, cortisol, norepinephrine, glucagon) were measured and compared to a control group without antecedent hypoglycemia.
Main Results:
- Low insulin antecedent hypoglycemia significantly blunted ACTH, cortisol, and norepinephrine responses compared to controls.
- High insulin antecedent hypoglycemia did not significantly blunt these counterregulatory responses.
- Cortisol, norepinephrine, and glucagon responses were greater following high insulin antecedent hypoglycemia than low insulin antecedent hypoglycemia.
Conclusions:
- A single episode of mild hypoglycemia impairs neuroendocrine counterregulation 18-24 hours later.
- Insulin exerts a moderate protective effect against the blunting of subsequent counterregulatory responses to hypoglycemia.
Related Concept Videos
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Oral Hypoglycemic Agents: Glinides
Hypoglycemia and Glucagon
Hypoglycemia

